Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00712751 · ClinicalTrials.gov registry record
The Sexual Health of Rectal Cancer Patients
A clinical trial of Rectal Cancer and RECTUM, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 192
- Enrollment target
- 2
- Study locations
NCT00712751 is a study of Rectal Cancer and RECTUM that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 192 participants, below the 3,164-participant average among 70 other Rectal Cancer trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT00712751, a study of Rectal Cancer and RECTUM, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 192 participants
- Enrollment target
- 2
- Study locations
Study Summary
We know that treatment for rectal, colorectal or anal cancer can impact sexual function. This study aims to learn: * How the treatment affects emotional and social well-being. * How a new sexual health educational program affects you. Cancer patients seek education for lots of reasons. It often helps them cope because they can express their feelings with a trained professional. This study is open to individuals who have been treated for rectal, colorectal or anal cancer. It involves a new type of sexual health counseling program. It will teach participants skills that they can use to improve their sex lives. These skills may also improve physical and emotional well-being. We will compare the new type of sexual health program with the standard care patients receive after treatment for rectal, colorectal or anal cancer.
Conditions Studied
Interventions
- BEHAVIORAL questionnaires
- BEHAVIORAL CSI-SH- Cancer Survivorship Intervention
Study Locations (2)
New York
- Mount Sinai Hospital - New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2008-06-24 |
| Est. Completion | 2024-11-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00712751
The ClinicalTrials.gov registry entry for NCT00712751 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,164-participant average among 70 other Rectal Cancer trials with a reported enrollment target (94% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Rectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which questionnaires is the first listed.
NCT00712751 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00712751 about?
NCT00712751 is a clinical study titled "The Sexual Health of Rectal Cancer Patients". We know that treatment for rectal, colorectal or anal cancer can impact sexual function. This study aims to learn: * How the treatment affects emotional and social well-being. * How a new sexual health educational program affects you. Cancer patients seek education for lots of reasons. It often he...
What is the current status of trial NCT00712751?
This trial is currently completed. The enrollment target is 192 participants. The study started on 2008-06-24. Estimated completion is 2024-11-21.
What conditions does trial NCT00712751 study?
This clinical trial studies the following conditions: Rectal Cancer, RECTUM.
What interventions are being tested in trial NCT00712751?
The interventions under investigation include: questionnaires (BEHAVIORAL), CSI-SH- Cancer Survivorship Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00712751?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00712751 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
RECRUITING · Phase 1
-
Exosomes in Rectal Cancer
RECRUITING
-
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
RECRUITING · Phase 2
-
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
RECRUITING · Phase 2
-
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.